Journal Article Scrutiny Increases In Recent FDA Ad Division Letters
Executive Summary
FDA is scrutinizing use of published studies in promotional campaigns more closely, recent untitled letters issued by the agency's Division of Drug Marketing, Advertising & Communication indicate.